Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
187
NCT00955786
Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2005
Completion: Dec 31, 2008
NCT00485966
Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Phase: Phase 2
Start: Jun 30, 2007
Completion: Jun 30, 2008
NCT00955292
Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas
Start: Jul 31, 2007
NCT00780663
Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
Start: Oct 31, 2008
Completion: Mar 31, 2010
NCT00891280
Dose-escalation Study of Oral CX-4945
Start: Feb 28, 2009
Completion: Dec 31, 2011
NCT01199718
Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
Start: Sep 30, 2010
Completion: Sep 30, 2011